Literature DB >> 8289310

Catalytic antibody model and mutagenesis implicate arginine in transition-state stabilization.

V A Roberts1, J Stewart, S J Benkovic, E D Getzoff.   

Abstract

To probe the mechanism of the catalytic antibody NPN43C9, we have constructed a three-dimensional model of the NPN43C9 variable region using our antibody structural database (ASD), which takes maximal advantage of immunoglobulin sequence and structural information. The ASD contains separately superimposed variable light and variable heavy chains, which reveal not only conserved backbone structure, but also structurally conserved side-chain conformations. The NPN43C9 model revealed that the guanidinium group of light chain Arg L96 was positioned at the bottom of the antigen-binding site and formed a salt bridge with the antigen's phosphonamidate group, which mimics the negatively charged, tetrahedral transition states in the hydrolysis reaction. Thus, the model predicts both binding and catalytic functions for Arg L96, which previously had not been implicated in either. First, Arg L96 should enhance antigen binding by electrostatically complementing the negative charge of the antigen, which is buried upon complex formation. Second, Arg L96 should promote catalysis by electrostatically stabilizing the negatively charged transition states formed during catalysis. These hypotheses were tested experimentally by design and characterization of the R-L96-Q mutant, in which Arg L96 was replaced with Gln by site-directed mutagenesis. As predicted, antigen binding in the R-L96-Q mutant was decreased relative to that in the parent NPN43C9 antibody, but binding of antigen fragments lacking the phosphonamidate group was retained. In addition, the R-L96-Q mutant had no detectable esterase activity. Thus, the computational model and experimental results together suggest a mechanism by which the catalytic antibody NPN43C9 stabilizes high-energy transition states during catalysis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8289310     DOI: 10.1006/jmbi.1994.1060

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  8 in total

1.  Cyclic peptide formation catalyzed by an antibody ligase.

Authors:  D B Smithrud; P A Benkovic; S J Benkovic; V Roberts; J Liu; I Neagu; S Iwama; B W Phillips; A B Smith; R Hirschmann
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

2.  Mechanistically different catalytic antibodies obtained from immunization with a single transition-state analog.

Authors:  J Guo; W Huang; G W Zhou; R J Fletterick; T S Scanlan
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

3.  Crystal structure of the complex of a catalytic antibody Fab fragment with a transition state analog: structural similarities in esterase-like catalytic antibodies.

Authors:  J B Charbonnier; E Carpenter; B Gigant; B Golinelli-Pimpaneau; Z Eshhar; B S Green; M Knossow
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

Review 4.  Dissection of an antibody-catalyzed reaction.

Authors:  J D Stewart; J F Krebs; G Siuzdak; A J Berdis; D B Smithrud; S J Benkovic
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-02       Impact factor: 11.205

5.  Energy landscape of chelated uranyl: antibody interactions by dynamic force spectroscopy.

Authors:  Michael Odorico; Jean-Marie Teulon; Thérèse Bessou; Claude Vidaud; Laurent Bellanger; Shu-wen W Chen; Eric Quéméneur; Pierre Parot; Jean-Luc Pellequer
Journal:  Biophys J       Date:  2007-04-20       Impact factor: 4.033

6.  Enhancement and destruction of antibody function by somatic mutation: unequal occurrence is controlled by V gene combinatorial associations.

Authors:  C Chen; V A Roberts; S Stevens; M Brown; M P Stenzel-Poore; M B Rittenberg
Journal:  EMBO J       Date:  1995-06-15       Impact factor: 11.598

7.  Engineering an efficient and enantioselective enzyme for the Morita-Baylis-Hillman reaction.

Authors:  Rebecca Crawshaw; Amy E Crossley; Linus Johannissen; Ashleigh J Burke; Sam Hay; Colin Levy; David Baker; Sarah L Lovelock; Anthony P Green
Journal:  Nat Chem       Date:  2021-12-16       Impact factor: 24.274

Review 8.  Essential Protective Role of Catalytically Active Antibodies (Abzymes) with Redox Antioxidant Functions in Animals and Humans.

Authors:  Anna S Tolmacheva; Georgy A Nevinsky
Journal:  Int J Mol Sci       Date:  2022-03-31       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.